Discover 715 paid clinical trials in Olathe, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 715
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
for
Eosinophilic Asthma
Location: Kansas City KS, Iowa City IA, Edmond OK, Madison WI,
Sponsor: Kymera Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07323654
Phase 2, Recruiting
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
for
Asthma
Location: Kansas City KS, St Louis MO, Maryville IL, McKinney TX,
Sponsor: Enveda Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07301255
Phase 2, Recruiting
An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy
for
Multiple System Atrophy
Location: Kansas City KS, Chicago IL, Pittsburgh PA, Durham NC,
Location: Kansas City KS, Topeka KS, St Louis MO, Little Rock AR,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18 - 70+
Code: NCT06419374
Phase 3, Recruiting
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
for
Parkinson Disease
Location: Kansas City KS, Chesterfield MO, Chicago IL, Aurora CO,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 40 - 70+
Code: NCT06976268
Phase 2, Phase 3, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Location: Kansas City KS, Springfield MO, Wichita KS, Omaha NE,
Sponsor: Sameek Roychowdhury
Sex: All
Age: 18+
Code: NCT06906562
Phase 2, Recruiting
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
for
Ulcerative Colitis, Crohn's Disease
Location: Kansas City MO, Columbia MO, Hutchinson KS,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06581328
Phase 4, Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
for
Aortic Stenosis, Calcific, Aortic Valve Stenosis
Location: Kansas City MO, Wichita KS, Tulsa OK, Jacksonville FL,
Sponsor: Edwards Lifesciences
Sex: All
Age: 65+
Code: NCT04889872
Recruiting
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
for
Focal Segmental Glomerulosclerosis
Location: Kansas City KS, Wichita KS, City of Saint Peters MO,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 12+
Code: NCT07220083
Phase 3, Recruiting
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
for
Hypertension (HTN)
Location: Kansas City MO, Jefferson City MO, Wichita KS,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07543120
Phase 2, Recruiting
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
for
B-cell Acute Lymphoblastic Leukemia, Obesity
Location: Kansas City KS, Minneapolis MN, Chicago IL, Dallas TX,
Sponsor: Etan Orgel
Sex: All
Age: 7 - 25
Code: NCT05082519
Phase 2, Recruiting
Continuous Monitoring and Control of Hypoglycemia
for
Diabetes
Location: Kansas City MO, Topeka KS, Oklahoma City OK,
Sponsor: DexCom, Inc.
Sex: All
Age: 2+
Code: NCT03340831
Recruiting
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
for
Atypical Teratoid/Rhabdoid Tumor,
Location: Kansas City KS, St Louis MO, Little Rock AR, Dallas TX,
Sponsor: Milton S. Hershey Medical Center
Sex: All
Age: 0 - 26
Code: NCT06465199
Phase 1, Phase 2, Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for
Rhabdomyosarcoma
Location: Kansas City MO, Wichita KS, Omaha NE, Des Moines IA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT07466316
Phase 3, Recruiting
Pilot Trial of Clinic-based Dating Violence Prevention Program for Adolescents and Caregivers
for
Dating Violence, Parent, Primary Care
Location: Kansas City KS, Monongahela PA
Sponsor: University of Pittsburgh
Sex: All
Age: 12+
Code: NCT07039253
Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Kansas City MO, Columbia MO, Wichita KS, Omaha NE,